National Institute of Mental Health (NIMH); Notice of Meeting, 63034 [2021-24839]

Download as PDF 63034 Federal Register / Vol. 86, No. 217 / Monday, November 15, 2021 / Notices Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E70A, Rockville, MD 208523, 240–627–3390, aabbey@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 8, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–24768 Filed 11–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health (NIMH); Notice of Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Autism Coordinating Committee. The purpose of the IACC meeting is to discuss business, agency updates, and issues related to autism spectrum disorder (ASD) research and services activities. The meeting will be held as a virtual meeting and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below at least seven (7) business days in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocast website (https://videocast.nih.gov/ watch=44055). Name of Committee: Interagency Autism Coordinating Committee (IACC). Date: January 19, 2022 Meeting schedule subject to change. Time: 10:00 a.m. to 5:00 p.m. Meeting Access: Wednesday, January 19, 2022 https://videocast.nih.gov/watch=44055. Agenda: To discuss business, updates, and issues related to ASD research and services activities. Cost: The meeting is free and open to the public. Registration: A registration web link will be posted on the IACC website (www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. Deadlines: Written/Virtual Public Comment Due Date: Friday, January 7, 2022, by 5:00 p.m. ET, For instructions, see below. Contact Person: Ms. Rebecca Martin, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Bethesda, MD 20892– VerDate Sep<11>2014 16:42 Nov 12, 2021 Jkt 256001 9669, Phone: 301–435–0886, Email: IACCPublicInquiries@mail.nih.gov. Public Comments The IACC welcomes public comments from members of the autism community. As the IACC will be updating its Strategic Plan, comments related to issues that the community would like to see highlighted in the new IACC Strategic Plan are welcome. Comments may be submitted in writing via email to IACCPublicInquiries@ mail.nih.gov or using the web form at: https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 p.m. ET on Friday, January 7, 2022. A limited number of slots are available for individuals to provide a 2–3-minute summary or excerpt of their written comment to the IACC live during the virtual meeting using the virtual platform. For those interested in that opportunity, please indicate ‘‘Interested in providing virtual comment’’ in your written submission, along with your name, address, email, phone number, and professional/organizational affiliation so that the Office of Autism Research Coordination staff can contact you if a slot is available for you to provide a summary or excerpt of your comment via the virtual platform during the meeting. For any given meeting, priority for virtual comment slots will be given to commenters who have not previously provided virtual comments in the current calendar year. This will help ensure that as many individuals as possible have an opportunity to share comments. Commenters going over their allotted 3-minute slot may be asked to conclude immediately to allow other comments and the rest of the meeting to proceed on schedule. Public comments received by 5:00 p.m. ET on Friday, January 7, 2022, will be provided to the IACC prior to the meeting for their consideration. Any written comments received after 5:00 p.m. ET, January 7, 2022, may be provided to the IACC either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. The IACC is not able to individually respond to comments. All public comments become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. For public comment guidelines, see: https:// iacc.hhs.gov/meetings/publiccomments/guidelines/. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Technical Issues If you experience any technical problems with the webcast, please email IACCPublicInquiries@mail.nih.gov. Disability Accommodations All IACC Full Meetings provide Closed Captioning through the NIH videocast website. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the request. Last-minute requests may be made, but may not be possible to accommodate. Additional Information Information about the IACC is available on the website: https:// www.iacc.hhs.gov. Dated: November 9, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–24839 Filed 11–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed). Date: December 8, 2021. E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 86, Number 217 (Monday, November 15, 2021)]
[Notices]
[Page 63034]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24839]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health (NIMH); Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Interagency Autism 
Coordinating Committee.
    The purpose of the IACC meeting is to discuss business, agency 
updates, and issues related to autism spectrum disorder (ASD) research 
and services activities. The meeting will be held as a virtual meeting 
and is open to the public. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below at 
least seven (7) business days in advance of the meeting. The open 
session will be videocast and can be accessed from the NIH Videocast 
website (https://videocast.nih.gov/watch=44055).

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Date: January 19, 2022 Meeting schedule subject to change.
    Time: 10:00 a.m. to 5:00 p.m.
    Meeting Access: Wednesday, January 19, 2022 https://videocast.nih.gov/watch=44055.
    Agenda: To discuss business, updates, and issues related to ASD 
research and services activities.
    Cost: The meeting is free and open to the public.
    Registration: A registration web link will be posted on the IACC 
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is 
recommended.
    Deadlines: Written/Virtual Public Comment Due Date: Friday, 
January 7, 2022, by 5:00 p.m. ET, For instructions, see below.
    Contact Person: Ms. Rebecca Martin, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Bethesda, MD 20892-9669, Phone: 301-435-0886, 
Email: [email protected].

Public Comments

    The IACC welcomes public comments from members of the autism 
community. As the IACC will be updating its Strategic Plan, comments 
related to issues that the community would like to see highlighted in 
the new IACC Strategic Plan are welcome. Comments may be submitted in 
writing via email to [email protected] or using the web 
form at: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp 
by 5:00 p.m. ET on Friday, January 7, 2022. A limited number of slots 
are available for individuals to provide a 2-3-minute summary or 
excerpt of their written comment to the IACC live during the virtual 
meeting using the virtual platform. For those interested in that 
opportunity, please indicate ``Interested in providing virtual 
comment'' in your written submission, along with your name, address, 
email, phone number, and professional/organizational affiliation so 
that the Office of Autism Research Coordination staff can contact you 
if a slot is available for you to provide a summary or excerpt of your 
comment via the virtual platform during the meeting. For any given 
meeting, priority for virtual comment slots will be given to commenters 
who have not previously provided virtual comments in the current 
calendar year. This will help ensure that as many individuals as 
possible have an opportunity to share comments. Commenters going over 
their allotted 3-minute slot may be asked to conclude immediately to 
allow other comments and the rest of the meeting to proceed on 
schedule.
    Public comments received by 5:00 p.m. ET on Friday, January 7, 
2022, will be provided to the IACC prior to the meeting for their 
consideration. Any written comments received after 5:00 p.m. ET, 
January 7, 2022, may be provided to the IACC either before or after the 
meeting, depending on the volume of comments received and the time 
required to process them in accordance with privacy regulations and 
other applicable Federal policies. The IACC is not able to individually 
respond to comments. All public comments become part of the public 
record. Attachments of copyrighted publications are not permitted, but 
web links or citations for any copyrighted works cited may be provided. 
For public comment guidelines, see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.

Technical Issues

    If you experience any technical problems with the webcast, please 
email [email protected].

Disability Accommodations

    All IACC Full Meetings provide Closed Captioning through the NIH 
videocast website. Individuals whose full participation in the meeting 
will require special accommodations (e.g., sign language or 
interpreting services, etc.) must submit a request to the Contact 
Person listed on the notice at least seven (7) business days prior to 
the meeting. Such requests should include a detailed description of the 
accommodation needed and a way for the IACC to contact the requester if 
more information is needed to fill the request. Last-minute requests 
may be made, but may not be possible to accommodate.

Additional Information

    Information about the IACC is available on the website: https://www.iacc.hhs.gov.

    Dated: November 9, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-24839 Filed 11-12-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.